Complete Barrett's eradication endoscopic mucosal resection: An effective treatment modality for high-grade dysplasia and intramucosal carcinoma - An American single-center experience

American Journal of Gastroenterology

Volumn 104, Issue 11, 2009, Pages 2684-2692

  Chennat, Jennifer ^a   Konda, Vani J A ^a   Ross, Andrew S ^a   De Tejada, Alberto Herreros ^a   Noffsinger, Amy ^a   Hart, John ^a   Lin, Shang ^a   Ferguson, Mark K ^a   Posner, Mitchell C ^a   Waxman, Irving ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER INVASION; CANCER SURGERY; CLINICAL EFFECTIVENESS; COMPLETE BARRETT ERADICATION ENDOSCOPIC MUCOSAL RESECTION; DISEASE SURVEILLANCE; DRUG MEGADOSE; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC SURGERY; EPITHELIUM DYSPLASIA; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; ESOPHAGUS RESECTION; ESOPHAGUS STENOSIS; ESOPHAGUS SURGERY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHATIC SYSTEM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NARROW BAND IMAGING; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TERTIARY HEALTH CARE; WHITE LIGHT ENDOSCOPY;

ACADEMIC MEDICAL CENTERS; ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; BIOPSY, NEEDLE; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; ILLINOIS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PRECANCEROUS CONDITIONS; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME;

EID: 72049105076     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.465     Document Type: Article

References (59)

1. Buttar NS, Wang KK, Sebo TJ et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001;120:1630-1639 (Pubitemid 32523482)
2. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005;97:142-146 (Pubitemid 40277094)
3. Ferguson MK, Naunheim KS. Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J Th orac Cardiovasc Surg 1997;114:824-829
4. Pellegrini CA, Pohl D. High-grade dysplasia in Barrett's esophagus: surveillance or operation? J Gastrointest Surg 2000;4:131-134
5. Konda VJ, Ross AS, Ferguson MK et al. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated? Clin Gastroenterol Hepatol 2008;6:159-164
6. Buskens CJ, Westerterp M, Lagarde SM et al. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc 2004;60:703-710 (Pubitemid 39550926)
7. Stein HJ, Feith M, Bruecher BL et al. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 2005;242:566-73;discussion 573-575
8. Pech O, Behrens A, May A et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with highgrade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008;57:1200-1206
9. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003;349:2241-2252
10. Birkmeyer JD, Siewers AE, Finlayson EV et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346:1128-1137 (Pubitemid 34984604)
11. Birkmeyer JD, Stukel TA, Siewers AE et al. Surgeon volume and operative mortality in the United States. N Engl J Med 2003;349:2117-2127
12. Guardino JM, Khandwala F, Lopez R et al. Barrett's esophagus at a tertiary care center: association of age on incidence and prevalence of dysplasia and adenocarcinoma. Am J Gastroenterol 2006;101:2187-2193 (Pubitemid 44477541)
13. O'Connor JB, Falk GW, Richter JE. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol 1999;94:2037-2042
14. May A, Ell C. Diagnosis and treatment of early esophageal cancer. Curr Opin Gastroenterol 2006;22:433-436 (Pubitemid 44090202)
15. Ell C, May A, Gossner L et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000;118:670-677 (Pubitemid 30171616)
16. Nijhawan PK, Wang KK. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. Gastrointest Endosc 2000;52:328-332
17. Buttar NS, Wang KK, Lutzke LS et al. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Gastrointest Endosc 2001;54:682-688
18. May A, Gossner L, Pech O et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 2002;14:1085-1091 (Pubitemid 35178769)
19. May A, Gossner L, Pech O et al. Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): curative treatment using local endoscopic treatment techniques. Endoscopy 2002;34:604-610 (Pubitemid 34863268)
20. Pech O, May A, Gossner L et al. Barrett's esophagus: endoscopic resection. Gastrointest Endosc Clin N Am 2003;13:505-512
21. Larghi A, Lightdale CJ, Memeo L et al. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus. Gastrointest Endosc 2005;62:16-23. (Pubitemid 40922435)
22. Mino-Kenudson M, Brugge WR, Puricelli WP et al. Management of superficial Barrett's epithelium-related neoplasms by endoscopic mucosal resection: clinicopathologic analysis of 27 cases. Am J Surg Pathol 2005;29:680-686 (Pubitemid 40577880)
23. Seewald S, Akaraviputh T, Seitz U et al. Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc 2003;57:854-859 (Pubitemid 47241100)
24. Giovannini M, Bories E, Pesenti C et al. Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. Endoscopy 2004;36:782-787
25. Peters FP, Kara MA, Rosmolen WD et al. Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study. Am J Gastroenterol 2006;101:1449-1457
26. Larghi A, Lightdale CJ, Ross AS et al. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy 2007;39:1086-1091
27. Japanese Gastric Cancer A. Japanese classification of gastric carcinoma - 2nd English edition. Gastric Cancer 1998;1:10-24.
28. Fleischer DE, Wang GQ, Dawsey S et al. Tissue band ligation followed by snare resection (band and snare): a new technique for tissue acquisition in the esophagus. Gastrointest Endosc 1996;44:68-72. (Pubitemid 26268663)
29. Inoue H, Takeshita K, Hori H et al. Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesions . Gastrointest Endosc 1993;39:58-62. (Pubitemid 23062896)
30. Soehendra N, Binmoeller KF, Bohnacker S et al. Endoscopic snare mucosectomy in the esophagus without any additional equipment: a simple technique for resection of fl at early cancer. Endoscopy 1997;29:380-383 (Pubitemid 27370857)
31. Montgomery E, Bronner MP, Goldblum JR et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 2001;32:368-378 (Pubitemid 32378298)
32. Reid BJ, Haggitt RC, Rubin CE et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988;19:166-178 (Pubitemid 18091022)
33. Abraham SC, Krasinskas AM, Correa AM et al. Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma. Am J Surg Pathol 2007;31:1719-1725
34. Lewis JT, Wang KK, Abraham SC. Muscularis mucosae duplication and the musculo-fibrous anomaly in endoscopic mucosal resections for barrett esophagus: implications for staging of adenocarcinoma. Am J Surg Pathol 2008;32:566-571
35. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with highgrade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 1996;224:66-71.
36. Falk GW, Rice TW, Goldblum JR et al. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia . Gastrointest Endosc 1999;49:170-176
37. Katada C, Muto M, Manabe T et al. Esophageal stenosis after endoscopic mucosal resection of superficial esophageal lesions. Gastrointest Endosc 2003;57:165-169 (Pubitemid 36236752)
38. Pouw RE, Peters FP, Sempoux C et al. Stepwise radical endoscopic resection for Barrett's esophagus with early neoplasia: report on a Brussels ' cohort. Endoscopy 2008;40:892-898
39. Barham CP, Jones RL, Biddlestone LR et al. Photothermal laser ablation of Barrett's oesophagus: endoscopic and histological evidence of squamous re-epithelialisation. Gut 1997;41:281-284
40. Biddlestone LR, Barham CP, Wilkinson SP et al. The histopathology of treated Barrett's esophagus: squamous reepithelialization after acid suppression and laser and photodynamic therapy. Am J Surg Pathol 1998;22:239-245
41. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982-993
42. Mino-Kenudson M, Ban S, Ohana M et al. Buried dysplasia and early adenocarcinoma arising in barrett esophagus after porfimer-photodynamic therapy. Am J Surg Pathol 2007;31:403-409 (Pubitemid 46673114)
43. Van Laethem JL, Peny MO, Salmon I et al. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus. Gut 2000;46:574-577 (Pubitemid 30305825)
44. van Hillegersberg R, Haringsma J, ten Kate FJ et al. Invasive carcinoma after endoscopic ablative therapy for high-grade dysplasia in Barrett's oesophagus . Dig Surg 2003;20:440-444
45. Kelty CJ, Ackroyd R, Brown NJ et al. Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation. Aliment Pharmacol Ther 2004;20 : 1289-1296 (Pubitemid 40040075)
46. Dulai GS, Jensen DM, Cortina G et al. Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. Gastrointest Endosc 2005;61:232-240 (Pubitemid 40261071)
47. Sharma P, Wani S, Weston AP et al. A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results. Gut 2006;55:1233-1239
48. Attwood SE, Lewis CJ, Caplin S et al. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol 2003;1:258-263
49. Pereira-Lima JC, Busnello JV, Saul C et al. High power setting argon plasma coagulation for the eradication of Barrett's esophagus. Am J Gastroenterol 2000;95:1661-1668
50. Ragunath K, Krasner N, Raman VS et al. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and costeff ectiveness. Scand J Gastroenterol 2005;40:750-758
51. Sharma VK, Wang KK, Overholt BF et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year followup of 100 patients. Gastrointest Endosc 2007;65:185-195 (Pubitemid 46157125)
52. Fleischer DE, Overholt BF, Sharma VK et al. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc 2008;68:867-876
53. Sharma VK, Jae Kim H, Das A et al. Circumferential and focal ablation of Barrett's esophagus containing dysplasia. Am J Gastroenterol 2009;104 : 310-317
54. Pech O, Gossner L, May A et al. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superfi cial Barrett's cancer and highgrade intraepithelial neoplasia. Gastrointest Endosc 2005;62:24-30. (Pubitemid 40922436)
55. Hage M, Siersema PD, van Dekken H et al. 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial. Gut 2004;53:785-790 (Pubitemid 38662126)
56. Peters F, Kara M, Rosmolen W et al. Poor results of 5-aminolevulinic acidphotodynamic therapy for residual high-grade dysplasia and early cancer in Barrett esophagus after endoscopic resection. Endoscopy 2005;37:418-424 (Pubitemid 40668206)
57. Gondrie JJ, Pouw RE, Sondermeijer CM et al. Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the fi rst prospective series of 11 patients. Endoscopy 2008;40:359-369 (Pubitemid 351696372)
58. Gondrie JJ, Pouw RE, Sondermeijer CM et al. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy 2008;40:370-379 (Pubitemid 351696373)
59. Pouw RE, Gondrie JJ, Sondermeijer CM et al. Eradication of Barrett esophagus with early neoplasia by radiofrequency ablation, with or without endoscopic resection. J Gastrointest Surg 2008;12:1627-36;discussion 1636-1637